Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancerQian Zhou, Liang Chen, Bo Li et al.|EMBO Molecular Medicine|2021Cited by 56
Targeting hyperactive TGFBR2 for treating MYOCD deficient lung cancerQian Zhou, Liang Chen, Wensheng Chen et al.|Theranostics|2021Cited by 30